Ramkrishna Forgings Limited announces Q1 FY2026-27 results and management changes
Ramkrishna Forgings · Auto Components
Key highlights
- Q1 FY2026-27 consolidated revenue from operations ₹1,216.67 crore; profit before tax ₹64.73 crore
- Chaitanya Jalan re-designated as Joint Managing Director effective 24 July 2026, term till 8 Nov 2029
- Approved capital expenditure ₹170.52 crore to add 8,800 MT forging capacity by Sept 2027, funded by equity and debt
Why it's rated major development: the year-on-year change is 298% (50% or more)
Figures checked against the filing by a second AI read. About the business, not the share price.
Original filing
Board Meeting Outcome for Outcome Of Board Meeting
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Ramkrishna Forgings
- Dividend / buyback / bonusNotableRamkrishna Forgings Limited appoints directors, amends MOA, invests ₹56.76 crore in JV
- Dividend / buyback / bonusNotableRamkrishna Forgings Ltd appoints directors, alters MOA, and approves JV investment
- Dividend / buyback / bonusMajor developmentRamkrishna Forgings Limited announces Q2 2026 results, director appointments, and more
- Capex / expansionMajor developmentRamkrishna Forgings Q1 FY27 PAT up 298%, announces ₹170 crore capex
- Credit ratingMajor development· Adverse for the businessRamkrishna Forgings Limited's bank loan ratings downgraded by India Ratings & Research
Other capex / expansion filings this fortnight
- Maharaja & Speedex India Limited raises manufacturing capacity to 72 lakh units/year
- Elin Electronics Q2 FY27 earnings report with 10% revenue growth and margin update
- HOAC Foods India Limited H1 FY27 Earnings Call Transcript dated November 5, 2026
- Gujarat State Fertilizers & Chemicals Limited Q2 FY27 Earnings Call Highlights
- Supriya Lifescience H1 revenue up 14.8% to ₹396.04 crore; Q2 profit falls
- V-MARC India Ltd announces Q2 & H1 FY27 unaudited financial results and review report
Potential multibaggers · Q2 FY27
Potential multibaggers in Auto Components
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.